# evAluation of Glycemic RangE During acutE Coronary syndroME in Nondiabetic paTients (AGREEMENT)

Study · id `cardio:ct-nct02932592` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02932592](<https://clinicaltrials.gov/study/NCT02932592>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02932592

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 196 participants.

## Technical summary

Registry record NCT02932592. Allocation not applicable; no masking; primary purpose diagnostic. Start 2016-03-16 (actual); primary completion 2017-03-25 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Phase 4
- Enrolled: 196 participants (enrolled count; ClinicalTrials.gov record NCT02932592, source copy `cardio:ctgov-nct02932592-2022-05-26`, retrieved 2026-10-31)
- Started: 2016-03-16 (actual) (ClinicalTrials.gov record NCT02932592, source copy `cardio:ctgov-nct02932592-2022-05-26`, retrieved 2026-10-31)
- Primary completion: 2017-03-25 (actual) (ClinicalTrials.gov record NCT02932592, source copy `cardio:ctgov-nct02932592-2022-05-26`, retrieved 2026-10-31)
- Completion: 2017-10-31 (actual) (ClinicalTrials.gov record NCT02932592, source copy `cardio:ctgov-nct02932592-2022-05-26`, retrieved 2026-10-31)
- Countries: Italy (ClinicalTrials.gov record NCT02932592, source copy `cardio:ctgov-nct02932592-2022-05-26`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02932592-2022-05-26`, retrieved 2026-10-31)

## The registry's words

- Brief title: evAluation of Glycemic RangE During acutE Coronary syndroME in Nondiabetic paTients (AGREEMENT)
- Acronym: AGREEMENT
- Condition: Acute Coronary Syndrome
- Intervention (Device): Continuous Glucose Monitoring System (i Pro 2 - Medtronic)
- Lead sponsor: University of Pavia
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: University of Pavia (`cardio:org-university-of-pavia`)

## Provenance

Content hash: bfa74d0fba1e6bf24e284981285cb308b780e620cfd65b7cf4adfd7c0e83c96f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
